Abstract
The etiology of systemic sclerosis (SSc) remains unknown; however, several occupational and environmental factors have been implicated. Our objective was to perform a meta-analysis of all studies published on SSc associated with occupational and environmental exposure. The review was undertaken by means of MEDLINE and SCOPUS from 1960 to 2014 and using the terms: “systemic,” “scleroderma,” or “systemic sclerosis/chemically induced” [MesH]. The Newcastle-Ottawa Scale was used for the qualifying assessment. The inverse variance-weighted method was performed. The meta-analysis of silica exposure included 15 case-control studies [overall OR 2.81 (95%CI 1.86–4.23; p < 0.001)] and 4 cohort studies [overall RR 17.52 (95%CI 5.98–51.37; p < 0.001)]; the meta-analysis of solvents exposure included 13 case-control studies (overall OR 2.00 [95%CI 1.32–3.02; p = 0.001); the meta-analysis of breast implants exposure included 4 case-control studies (overall OR 1.68 (95%CI 1.65–1.71; p < 0.001)) and 6 cohort studies (overall RR 2.13 (95%CI 0.86–5.27; p = 0.10)); the meta-analysis of epoxy resins exposure included 4 case-control studies (overall OR 2.97 (95%CI 2.31–3.83; p < 0.001)), the meta-analysis of pesticides exposure included 3 case-control studies (overall OR 1.02 (95%CI 0.78–1.32; p = 0.90)) and, finally, the meta-analysis of welding fumes exposure included 4 studies (overall OR 1.29 (95%CI 0.44–3.74; p = 0.64)). Not enough studies citing risks related to hair dyes have been published to perform an accurate meta-analysis. Silica and solvents were the two most likely substances related to the pathogenesis of SSc. While silica is involved in particular jobs, solvents are widespread and more people are at risk of having incidental contact with them.
Similar content being viewed by others
References
Bramwell B (1914) Diffuse sclerodermia: its frequency; its occurrence in stone-masons; its treatment by fibrolysin-elevations of temperature due to fibrolysin injections. Edinburgh Med J 12:387–340
Erasmus LD (1957) Scleroderma in gold-miners on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med 3:209–231
McHugh NJ, Whyte J, Harvey G, Haustein UF (1994) Anti-topoisomerase I antibodies in silica associated systemic sclerosis. A model for autoimmunity. Arthritis Rheum 37:1198–1205
McCormic ZD, Khuder SS, Aryal BK, Ames AL, Khuder SA (2010) Occupational silica exposure as a risk factor for scleroderma: a meta-analysis. Int Arch Occup Environ Health 83:763–769
Bovenzi M, Barbone F, Betta A, Tommasini M, Versini W (1995) Scleroderma and occupational exposure. Scand J Work Environ Health 21:289–292
Bovenzi M, Barbone F, Pisa FE, Betta A, Romeo L, Tonello A (2004) A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 77:10–16
Rodnan GP, Benedek TG, Medsger TA Jr, Cammarata RJ (1967) The association of progressive systemic sclerosis (scleroderma) with coal miner’s pneumoconiosis and other forms of silicosis. Ann Intern Med 66:323–334
Sluis-Cremer GK, Hessel PA, Nizdo EH, Churchill AR, Zeiss EA (1985) Silica, silicosis and progressive systemic sclerosis. BJ Ind Med 42:838–843
Ziegler V, Enderlein G, Mehlhorn J (1997) Retrospective epidemiological analysis of the relation between progressive systemic scleroderma and the exposure to quartz dust out of uranium ore mining in East Germany. Zentralbl Arbeitsmed 47:7–13
Brown LM, Gridley J, Olsen JH, Mellemkjaer L, Linet MS, Fraumeni JF Jr (1997) Cancer risk and mortality patterns among silicotic men in Sweden and Denmark. J Occup Environ Med 39:633–638
Mehlhorn J, Enderlein G, Conrad K (1999) Analysis for the association between progressive systemic scleroderma exposure to quartz dust and silicosis in east German uranium mining. Zbl Arbeitsmed 49:134–147
Englert H, Small-Mcmahon J, Davis K et al (2000) Male systemic sclerosis and occupational silica exposure—a population-based study. Aust NZ J Med 30:215–220
Burns CJ, Laing TJ, Gillespie BW et al (1996) The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol 23:1904–1911
Walsh SJ (1999) Effects of non-mining occupational silica exposure on proportional mortality from silicosis and systemic sclerosis. J Rheumatol 26:2179–2185
Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT (2003) Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 60:122–129
Lacey JV, Laing TJ, Gillespie BW (1997) Epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol 24:1854–1855
Gold LS, Ward MH, Dosemeci M, De Roos AJ (2007) Systemic autoimmune disease mortality and occupational exposures. Arthritis Rheum 56:3189–3201
Rosenman KD, Moore-Fuller M, Reilly MJ (1999) Connective tissue disease and silicosis. Am J Ind Med 35:375–381
Silman AJ, Jones S (1992) What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 51:1322–1324
Makol A, Reilly MJ, Rosenman KD (2011) Prevalence of connective tissue disease in silicosis (1985-2006)-a report from the state of Michigan surveillance system for silicosis. Am J Ind Med 54:255–262
Maitre A, Hours M, Bonneterre V et al (2004) Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol 31:2395–2401
Diot E, Lesire V, Guilmot JL et al (2002) Systemic sclerosis and occupational risk factors: a case control study. Occup Environ Med 59:545–549
Mora G. 2003 Esclerodermia inducida por sílice. Tesis Doctoral. Facultad de Medicina, Universidad de Buenos Aires, Argentina.
Thompson AE, Pope JE (2002) Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J Rheumatol 29:1867–1873
Marie I, Gehanno JF, Bubenheim M et al (2014) Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 13:151–156
Zachariae H, Bjerring P, Søndergaard KH, Halkier-Sørensen L (1997) Occupational systemic sclerosis in men. Ugeskr Laeger 159:2687–2689
Freire M, Alonso M, Rivera A, Sousa A, Soto A, Gómez-Sousa JM, Baroja A, Vázquez-Triñanes C, Sopeña B (2015) Clinical peculiarities of patients with scleroderma exposed to silica: a systematic review of the literature. Semin Arthritis Rheum 45:294–300
Reinl W (1957) Scleroderma caused by trichloroethylene effects. Zentralbl Arbeitsmed 7:58–60
Walder G (1965) Solvents and scleroderma. Lancet 28:436–437
Aryal BK, Khuder SA, Schaub EA (2001) Meta-analysis of systemic sclerosis and exposure to solvents. Am J Ind Med 40:271–274
Kettaneh A, Al Moufti O, Tiev KP, Chayet C, Tolédano C, Fabre B et al (2007) Occupational exposure to solvents and gender-related risk of systemic sclerosis: a meta-analysis of case-control studies. J Rheumatol 34:97–103
Barragán-Martínez C, Speck-Hernández CA, Montoya-Ortiz G, Mantilla RD, Anaya JM, Rojas-Villarraga A (2012) Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis. PLoS One 7:1–18
Garabrant DH, Lacey JV, Laing TJ et al (2003) Scleroderma and solvent exposure among women. Am J Epidemiol 157:493–500
Lacey JV, Garabrant DH, Gillespie BW (1997) Self-reported exposure to solvents in women with systemic sclerosis. Arthritis Rheum 40:1021
Laing TJ, Gillespie B, Burns C (1995) Risk factors for scleroderma among Michigan women. Arthritis Rheum 38(suppl 9):S341
Czirjak L, Bokk A, Csontos G, Lörincz G, Szegedi G (1989) Clinical findings in 61 patients with progressive systemic sclerosis. Acta Derm Venereol 69:533–536
Goldman JA (1996) Connective tissue disease in people exposed to organic chemical solvents. Systemic sclerosis (scleroderma) in dry cleaning plant and aircraft industry workers. J Clin Rheumatol 2:185–190
Nietert PJ, Sutherland SE, Silver RM et al (1998) Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 41:1111–1118
Czirják L, Kumánovics G (2002) Exposure to solvents in female patients with scleroderma. Clin Rheumatol 21:114–118
Arnaud J, De Gaudemaris R, Carpentier P (2002) Sclérodermie et facteurs professionneles de l’environnment : étude cas-témoins en population générale. Arch Mal Prof 63:144
Kütting B, Uter W, Drexler H (2006) Is occupational exposure to solvents associated with an increased risk for developing systemic scleroderma? J Occup Med Toxicol 1:1–6
Garabrant DH, Dumas C (2000) Epidemiology of organic solvents and connective tissue disease. Arthritis Res 2:5–15
Sverdrup B (1984) Do workers in the manufacturing industry run an increased risk of getting scleroderma? Int J Dermatol 23:629
Lundberg I, Alfredsson L, Plato N, Sverdrup B, Klareskog L, Kleinau S (1994) Occupation, occupational exposure to chemicals and rheumatological disease. Scand J Rheumatol 23:305–310
Perkins LL, Clark BD, Klein PJ, Cook RR (1995) A meta-analysis of breast implants and connective tissue disease. Ann Plast Surg 35:561–570
Hochberg MC, Perlmutter DL (1996) The association of augmentation mammoplasty with connective tissue disease, including systematic sclerosis (scleroderma): a meta-analysis. Curr Top Microbiol Immunol 210:411–417
Wong O (1996) A critical assessment of the relationship between silicone breast implants and connective tissue diseases. Regul Toxicol Pharmacol 23:74–85
Whorton D, Wong O (1997) Scleroderma and silicone breast implants. West J Med 167:159–165
Janowsky EC, Kupper LL, Hulka BS (2000) Meta-analysis of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 342:781–790
Gabriel SE, O’Fallon M, Kurland LT, Beard CM, Woods JE, Melton LJ 3rd (1994) Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 24:1697–1702
Brinton L, Buckley LM, Dvorkina O, Lubin JH, Colton T, Murray MC (2004) Risk of connective tissue disorders among breast implant patients. Am J Epidemiol 160:619–627
McLaughlin JK, Fraumeni JF, Olsen J, Mellemkjaer L (1994) Breast implants, cancer and systemic sclerosis. J Natl Cancer Inst 86:424
Kjoller K, Friis S, Mellemkjaer L et al (2001) Connective tissue disease and other rheumatic conditions following cosmetic breast implantation in Denmark. Arch Intern Med 161:973–979
Goldman JA, Greenblatt J, Joines R, White L, Aylward B, Lamm SH (1995) Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice. J Clin Epidemiol 48:571–582
Fryzek JP, Holmich L, Mclaughlin JK et al (2007) A nationwide study of connective tissue disease and other rheumatic conditions among Danish women with long-term cosmetic breast implantation. Ann Epidemiol 17:374–379
Englert HJ, Brooks P (1994) Scleroderma and augmentation mammoplasty- a causal relationship? Aust NZ J Med 24:74–79
Hochberg MC, Perlmutter DL, Medsger T et al (1996) Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis Rheum 39:1125–1131
Wigley FM, Miller R, Hochberg MC (1992) Augmentation mammoplasty in patients with systemic sclerosis: data from the Baltimore scleroderma research center and Pittsburgh scleroderma data bank. Arthritis Rheum 35(Suppl 9):S46
Hennekens CH, Lee IM, Cook NR et al (1996) Self-reported breast implants and connective-tissue diseases in female health professionals. JAMA 275:616–621
Yamakage A, Ishikawa H, Saito Y, Hattori A (1980) Occupational scleroderma like disorder occurring in men engaged in the polymerization of epoxy resins. Dermatologica 161:33–44
Freni-Titulaer LWJ, Kelley DB, Grow AG, McKinley TW, Arnett FC, Hochberg MC (1989) Connective tissue disease in southeastern Georgia: a case-control study of etiologic factors. Am J Epidemiol 130:404–409
Wilson RH, McCormick WE, Tatum CF, Creech JL (1967) Occupational acroosteolysis. Report of 31 cases. JAMA 201:577–581
Veltman G, Lange CE, Jühe S, Stein G, Bachner U (1975) Clinical manifestations and course of vinyl chloride disease. Ann N Y Acad Sci 246:6–17
Ward AM, Udnoon S, Watkins J, Walker AE, Darke CS (1976) Immunological mechanisms in the pathogenesis of vinyl chloride disease. Br Med J 1:936–938
Posada de la Paz M, Philen RM, Abaitua I (2001) Toxic oil syndrome: the perspective after 20 years. Epidemiol Rev 23:231–247
Mayes MD (1999) Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect 107:743–748
Hess EV (2002) Environmental chemicals and autoimmune disease: cause and effect. Toxicology 181-2:65–70
Magnant J, Diot E (2006) Sclérodermie systémique : épidémiologie et facteurs environnementaux. Presse Med 35:1894–1901
Haustein UF, Ziegler V (1985) Environmentally induced systemic sclerosis-like disorders. Int J Dermatol 24:147–151
Fishman SJ, Russo GG (1991) The toxic pseudosclerodermas. Int J Dermatol 30:837–842
Cooper GS, Miller FW, Germolec DR (2002) Occupational exposures and autoimmune diseases. Int Immunopharmacol 2:303–313
Silman AJ, Hochberg MC (1996) Occupational and environmental influences on scleroderma. Rheum Dis Clin N Am 4:737–747
Steen VD (1999) Occupational scleroderma. Curr Opin Rheumatol 11:490–494
Hallé O, Schaeverbeke T, Bannwarth B, Dehais J (1997) Les facteurs d’environment et les éléments iatrogènes dans la sclérodermie systémique et les syndromes apparentés. Revue de la littérature. Rev Méd Interne 18:219–229
Granel B, Zemour F, Lehucher-Michel MP, Moulin P, Disdier P, Durand JM et al (2008) Évaluation de l’exposition toxique professionnelle de patients atteints de sclérodermie systémique. Revue de la lilttérature et résultat d’un auto-questionnaire. Rev Méd Interne 29:891–900
Straniero NR, Furst DE (1989) Environmentally-induced systemic sclerosis-like illness. Baillieres Clin Rheumatol 3:63–79
Nietert PJ, Silver RM (2000) Systemic sclerosis: environmental and occupational risk factors. Curr Opin Rheumatol 12:520–526
Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM et al (2012) Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun 39:259–271
D’Cruz D (2000) Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 112-113:421–432
Dospinescu P, Jones GT, Basu N (2013) Environmental risk factors in systemic sclerosis. Curr Opin Rheumatol 25:179–183
Schaeverbeke T, Hallé O, Moride Y (1995) Systemic sclerosis and prolonged exposure to toxics. Arthritis Rheum 38(Suppl 9):S332
Wells G, Shea B, O’Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. http://www.ohri.ca/programs/clinical_epidemiology /oxford.htm.
Kahn HA, Sempos CT.1989. Statistical Q14 methods in epidemiology. Oxford University Press.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
Begg CB, Berlin JA (1989) Publication bias and dissemination of clinical research. J Natl Cancer Inst 81:107–115
Acknowledgements
Special acknowledgment is given to Sandra Stroo from Dallas, Texas (USA), for the revision of the present study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There is neither financial support nor conflict of interest.
The authors declare no conflict of interest, no source of funding or sponsors or any relationship to organizations that could potentially influence the present work.
Financial support
None
Rights and permissions
About this article
Cite this article
Rubio-Rivas, M., Moreno, R. & Corbella, X. Occupational and environmental scleroderma. Systematic review and meta-analysis. Clin Rheumatol 36, 569–582 (2017). https://doi.org/10.1007/s10067-016-3533-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-016-3533-1